|
|
|
| |
 |
|
General and Oncologic Surgery; GI/Oncologic Surgery; Minimally Invasive Laparoscopic Surgery
Associate Professor, Mercer University
School of Medicine, Department of Surgery
4700 Waters Avenue
Savannah, GA 31404
912-350-2299
Legacy Center
14 Okatie Center Blvd. South
Suite 100
Okatie, SC 29909
To make an appointment:
Phone: 912-350-2299
Fax: 912-350-2298
Web Page: ACI
-- Surgical Associates
Memorial Minimally Invasive Surgery
|
|
Clinical Expertise: Gallbladder (among the first surgeons in the nation to offer the scarless technique for gallbladder removal), Pancreatic, Liver and Reflux disease, minimally invasive surgical approaches to the Esophagus and Liver (both benign and malignant diseases), Reoperative surgery, Hernia.
Medical Education: Harvard Medical
School, Boston
Residency: Mount Sinai Medical Center,
New York
Fellowship: Surgical Critical Care/Trauma,
Jackson Memorial Hospital, University of Miami School
of Medicine
Board Certification: General Surgery,
Surgical Critical Care
Professional Affiliations: American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), American Hepato Pancreato Biliary Association (AHPBA), Society of Surgical Oncology's Coding and Reimbursement Committee, American College of Surgeons Oncology Group (ACOSOG), American Association for the Surgery of Trauma, Association of Program Directors in Surgery (APDS)
Research Interests: Acute pancreatitis global consensus definition statement and EBM, ACOSOG E2202, Minimally Invasive Esophagectomy: A Multicenter Feasibility Study, An intergroup randomized phase II study of bevacizumab or cetuximab in combination with gemcitabine and in combination with chemoradiation in patients with completely resected pancreatic carcinoma, Neoadjuvant chemoradiation with oxaliplatin and capecitabine for patients with surgically respectable gastric cancer, Oxaliplatin plus protracted 5 fu and radiation for potentially curable esophageal cancer: A phase II trial with molecular correlates, Phase III randomized double blind study of adjuvant ST1571 versus placebo in patients following the resection of primary gastrointestinal stromal tumors, Flexible transgastric peritoneoscopy: feasibility and applicability in large animal model.
Meet other members of the surgical oncology team.
|
|